4//SEC Filing
DESOUZA ERROL B 4
Accession 0000899243-22-024038
CIK 0001802768other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:55 PM ET
Size
4.9 KB
Accession
0000899243-22-024038
Insider Transaction Report
Form 4
DESOUZA ERROL B
Director
Transactions
- Award
Class A Ordinary Shares
2022-06-24+6,328→ 56,698 total
Footnotes (1)
- [F1]Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001213895
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:55 PM ET
- Size
- 4.9 KB